Pharmaceutical Sector

Indo-SA Bilateral Trade Likely To Reach $12 Bn By 2010

New Delhi: Industry body FICCIFICCI President has stated that trade between India and S

BSE Sensex welcomes DLF Limited, kicks out Dr Reddy's Laboratories

DLF Limited BSE Sensex

FDA To Think About Drug Category Between Rx and OTC

FDARockville: The FDA will assemble a public trial by next month to think about formalizing a dispensing g

Ranbaxy Labs is good investment at current levels

As per views of Technical Analysts, Ranbaxy Labs is looking very fairly valued at current market price. The stock ended at 433.10 levels on Friday, down by Rs 9.20 or 2.08%.

Ranbaxy gets USFDA nod for Clarithromycin

Ranbaxy Clarithromycin FDA Pharyngitis

USFDA Approves Sanofi’s ‘Taxotere’ For Head, Neck Cancer

Paris: Sanofi-Aventis, French pharmaceutical group has annunciated that the U.S. health officials have approved another application of its anti-cancer drug ‘Taxotere.’

The company said that the drug has been sanctioned to treat locally advanced head and neck cancer before chemo-radiotherapy and surgical treatment.

The approval is based on the outcomes of a phase III clinical examination, which showed that adding up Taxotere to typical induction chemotherapy resulted in a more than three year betterment in patient endurance rate.

Pages